Emergent BioSolutions Inc (EBS)
1.95
-0.23
(-10.55%)
USD |
NYSE |
Apr 25, 16:00
1.97
+0.02
(+1.03%)
After-Hours: 20:00
Emergent BioSolutions Total Assets (Quarterly): 1.823B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.823B |
September 30, 2023 | 1.893B |
June 30, 2023 | 2.179B |
March 31, 2023 | 2.950B |
December 31, 2022 | 3.166B |
September 30, 2022 | 2.908B |
June 30, 2022 | 2.735B |
March 31, 2022 | 2.780B |
December 31, 2021 | 2.958B |
September 30, 2021 | 2.868B |
June 30, 2021 | 2.915B |
March 31, 2021 | 2.900B |
December 31, 2020 | 2.883B |
September 30, 2020 | 2.616B |
June 30, 2020 | 2.466B |
March 31, 2020 | 2.279B |
December 31, 2019 | 2.327B |
September 30, 2019 | 2.334B |
June 30, 2019 | 2.321B |
March 31, 2019 | 2.154B |
December 31, 2018 | 2.229B |
September 30, 2018 | 1.174B |
June 30, 2018 | 1.139B |
March 31, 2018 | 1.068B |
December 31, 2017 | 1.070B |
Date | Value |
---|---|
September 30, 2017 | 1.024B |
June 30, 2017 | 970.48M |
March 31, 2017 | 951.64M |
December 31, 2016 | 970.11M |
September 30, 2016 | 932.03M |
June 30, 2016 | 1.056B |
March 31, 2016 | 1.036B |
December 31, 2015 | 1.037B |
September 30, 2015 | 976.55M |
June 30, 2015 | 943.32M |
March 31, 2015 | 917.84M |
December 31, 2014 | 938.69M |
September 30, 2014 | 869.29M |
June 30, 2014 | 837.25M |
March 31, 2014 | 823.25M |
December 31, 2013 | 626.63M |
September 30, 2013 | 595.46M |
June 30, 2013 | 555.61M |
March 31, 2013 | 538.38M |
December 31, 2012 | 564.23M |
September 30, 2012 | 540.02M |
June 30, 2012 | 527.14M |
March 31, 2012 | 514.69M |
December 31, 2011 | 546.86M |
September 30, 2011 | 512.96M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.823B
Minimum
Dec 2023
3.166B
Maximum
Dec 2022
2.595B
Average
2.735B
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
Avid Bioservices Inc | 455.23M |
Viking Therapeutics Inc | 967.52M |
FibroGen Inc | 423.53M |
Avinger Inc | 13.77M |
RAPT Therapeutics Inc | 173.33M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.174B |
Shareholders Equity (Quarterly) | 649.30M |
Debt to Equity Ratio | 1.325 |
Current Ratio | 1.043 |
Net Debt Paydown Yield | 30.83% |